Edition:
United Kingdom

Essa Pharma Reports Qtrly Loss Per Share Of $0.07


Tuesday, 12 Dec 2017 

Dec 11 (Reuters) - ESSA Pharma Inc ::ESSA PHARMA ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL FOURTH QUARTER AND YEAR ENDED SEPTEMBER 30, 2017.QTRLY BASIC AND DILUTED LOSS PER COMMON SHARE $0.07‍​.‍CASH ON HAND AS AT SEPTEMBER 30, 2017 WAS $3.98 MILLION, WITH WORKING CAPITAL OF $1.28 MILLION​.